您的位置:首页 > 产品中心 > 212141-51-0, Vatalanib dihydrochloride
Vatalanib dihydrochloride
产品价格查看更多规格...
| 产品编号 | 包装单位 | 单价(元) | 国内现货 | 国外库存 | 询价单 |
| 4141339 | 10 MG | 702 | 2-5天 | 4-6周 | |
| 4141339 | 50 MG | 2260 | 2-5天 | 4-6周 |
产品别名
212141-51-0
Vatalanib dihydrochloride
1-(4-Chloroanilino)-4-(4-pyridylmethyl)phthalazine dihydrochloride
CGP 79787D dihydrochloride
N-(4-Chloroanilino)-4-(pyridin-4-ylmethyl)phthalazin-1-amine dihydrochloride
ZK-222584 dihydrochloride
PTK 787 dihydrochloride
ZK222584 dihydrochloride
PTK787 dihydrochloride
ZK 222584 dihydrochloride
CGP 79787 dihydrochloride
结构式
基本信息
| Empirical Formula【经验(实验)分子式】 | C20H15ClN4 · 2HCl |
| Molecular weight | 419.73 |
| MDL number | MFCD08458963 |
| Biochem/physiol Actions【生化/生理作用】 | Vatalanib (PTK787, ZK 222584, CGP 79787D, CGP 79787 succinate) is an orally active anilinophthalazine derivative that exerts its anti-angiogenic efficacy by targeting receptor tyrosine kinase (RTK) VEGFR (VEGFR1/2 IC50 = 54/39 nM; IC50 ∼30 nM against 100 ng/mL VEGF-C-induced VEGFR3 autophosphorylation in MEVCs) and, to a less extent, PDGFRβ, c-kit, c-fms (IC50 = 364, 600, 567 nM, respectively) in an ATP-competitive manner with much reduced or no potency toward >90 other kinases. Typical dosing ranges: 0.1-10 μM in cultures, 5 nM-200 μM (zebrafish) and 30-100 mg/kg (mice & rats via po. or ip) in vivo. |
产品性质
| Assay【测定】 | ≥98% (HPLC) |
| form【形式】 | powder |
| storage condition【储存条件】 | desiccated |
| color【颜色】 | white to beige |
| solubility【溶解性】 | H2O: 2 mg/mL, clear |
| storage temp.【储存温度】 | 2-8℃ |
| SMILES string | ClC(C=C1)=CC=C1NC2=NN=C(CC3=CC=NC=C3)C4=CC=CC=C42 |
安全信息
| Storage Class Code【储存分类代码】 | 13 - Non Combustible Solids |
| WGK | WGK 3 |




